RaySearch's VMAT solution launched by Philips

RaySearch's VMAT solution launched by Philips

RaySearch Laboratories' partner Royal Philips Electronics, has announced that
the new treatment planning solution SmartArc has received 510(k) clearance and
has been introduced on the market. The product has been developed in
collaboration with Philips as a part of the long standing partnership between
the two companies. SmartArc is a solution for volumetric modulated arc therapy
(VMAT) treatment planning. Available as a module in Philips' Pinnacle3 version 9
radiation treatment planning software, the new planning option can be used with
any VMAT-capable delivery system on the market.

VMAT (Volumetric Modulated Arc Therapy) is an advanced form of IMRT (Intensity
Modulated Radiation Therapy) in which the treatment machine rotates around the
patient while the treatment beam is on. The basic promise of VMAT delivery is to
significantly reduce treatment time per patient compared with traditional IMRT.
VMAT can benefit the patient by offering shorter treatment times, increased
accuracy and better sparing of healthy tissue. Reduced treatment time results in
decreased stress for patients and increased capacity for providers.

SmartArc advanced treatment planning technology allows single or multiple,
user-definable arcs and supports both constant- and variable-dose rate delivery.
Constant-dose rate delivery allows clinicians to explore the benefits of VMAT
delivery without the expense and downtime associated with an upgrade to their
linear accelerator. SmartArc is the first commercially released inverse planning
solution designed for both Elekta and Varian linear accelerators. This
flexibility is important to allow clinicians the freedom to choose the delivery
device that best fits their needs.

“SmartArc is a very powerful extension of the market-leading Pinnacle3 system.
It is by far the most versatile VMAT solution on the market as it can handle a
variety of options for all relevant treatment machines. I believe that this will
be highly appreciated by the Pinnacle3 users as it enables them to realize the
faster and better treatments that VMAT promises without extensive hardware
upgrades,” says Johan Löf, President of RaySearch.

“Over the years, RaySearch's advanced development capabilities have been
instrumental to realize several of the innovative treatment planning concepts
provided in Pinnacle3. SmartArc continues the tradition, enabling a wide range
of new treatment options benefitting clinics and patients alike,” adds Keith
Tipton, General Manager, Philips Radiation Oncology Solutions.

FOR FURTHER INFORMATION, CONTACT:
Johan Löf, President and CEO, RaySearch Laboratories AB
Telephone: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com


ABOUT RAYSEARCH
RaySearch Laboratories is a medical technology company that develops advanced
software solutions for improved radiation therapy of cancer. RaySearch's
products are sold through license agreements with leading partners such as
Philips, Varian, Nucletron, IBA Dosimetry and TomoTherapy. Eight products have
been released to date and RaySearch's software is used at over 1,300 clinics in
more than 30 countries. In addition, existing license agreements cover more than
15 other products that are scheduled to be launched in the coming years.
RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in
Stockholm and the company is listed in the SmallCap segment on the OMX Nordic
Exchange Stockholm. 

For more information about RaySearch, please visit www.raysearchlabs.com.